Viewing Study NCT00353366

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2026-02-03 @ 7:20 AM
Study NCT ID: NCT00353366
Status: COMPLETED
Last Update Posted: 2021-03-16
First Post: 2006-07-17
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infections, Rotavirus View
None Rotavirus Vaccines View
Keywords:

Keywords

Keyword Brief Keyword Text View
None safety View
None Post-marketing surveillance (PMS) View
None Rotarix View
None oral View
None Filipino View
None Rotavirus View
None Gastroenteritis View
None Human Rotavirus (HRV) vaccine View